Literature DB >> 3165705

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.

R Pieters1, D R Huismans, A Leyva, A J Veerman.   

Abstract

The reduction of the tetrazolium salt MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) to a blue-black formazan product by living but not by dead cells can be used to measure chemosensitivity of tumor cells. The main advantages of the MTT assay are its simplicity, rapidity, and the fact that the results are read automatically with a microplate spectrophotometer. Several reports on the use of the MTT assay in chemosensitivity testing have been published, but all these studies dealt with established cell lines and not with specimens obtained directly from patients. Here we present a study in which the MTT assay has been adapted to assess the effect of antineoplastic drugs on lymphoblasts of children with leukemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165705     DOI: 10.1016/0304-3835(88)90294-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Mechanical effects, antimicrobial efficacy and cytotoxicity of usnic acid as a biofilm prophylaxis in PMMA.

Authors:  Sunghwan Kim; Robert Greenleaf; Mark Carl Miller; Latha Satish; Sandeep Kathju; Garth Ehrlich; J Christopher Post; Nicholas G Sotereanos; Paul Stoodley
Journal:  J Mater Sci Mater Med       Date:  2011-09-22       Impact factor: 3.896

2.  A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.

Authors:  S-H Chen; W Yang; Y Fan; G Stocco; K R Crews; J J Yang; S W Paugh; C-H Pui; W E Evans; M V Relling
Journal:  Leukemia       Date:  2010-11-12       Impact factor: 11.528

3.  Extreme drug resistance in primary brain tumors: in vitro analysis of 64 resection specimens.

Authors:  Raymond I Haroun; Richard E Clatterbuck; M Christopher Gibbons; Peter C Burger; Ricardo Parker; John P Fruehauf; Henry Brem
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

Review 4.  In vitro assays for the evaluation of drug resistance in tumor cells.

Authors:  Jozef Hatok; Eva Babusikova; Tatiana Matakova; Dusan Mistuna; Dusan Dobrota; Peter Racay
Journal:  Clin Exp Med       Date:  2008-09-26       Impact factor: 3.984

5.  Cytotoxicity screening of Bangladeshi medicinal plant extracts on pancreatic cancer cells.

Authors:  Sherine George; Siddharth V Bhalerao; Erich A Lidstone; Irfan S Ahmad; Atiya Abbasi; Brian T Cunningham; Kenneth L Watkin
Journal:  BMC Complement Altern Med       Date:  2010-09-17       Impact factor: 3.659

6.  Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia.

Authors:  Faith Galderisi; Linda Stork; Ju Li; Motomi Mori; Solange Mongoue-Tchokote; James Huang
Journal:  Pediatr Blood Cancer       Date:  2009-10       Impact factor: 3.167

7.  Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

Authors:  M Haber; J Madafiglio; M D Norris
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury.

Authors:  Swasti Chaturvedi; Darren A Yuen; Amandeep Bajwa; Yi-Wei Huang; Christiane Sokollik; Liping Huang; Grace Y Lam; Soumitra Tole; Guang-Ying Liu; Jerry Pan; Lauren Chan; Yaro Sokolskyy; Manoj Puthia; Gabriela Godaly; Rohan John; Changsen Wang; Warren L Lee; John H Brumell; Mark D Okusa; Lisa A Robinson
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

9.  Seprase, a membrane-bound protease, alleviates the serum growth requirement of human breast cancer cells.

Authors:  Johnna D Goodman; Tricia L Rozypal; Thomas Kelly
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells.

Authors:  Xuan-Fu Xu; Chuan-Yong Guo; Jun Liu; Wen-Juan Yang; Yu-Jing Xia; Ling Xu; Yong-Chun Yu; Xing-Peng Wang
Journal:  J Carcinog       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.